Suppr超能文献

可控制递送达纤维化生长因子-1 和神经调节蛋白-1 的生物可降解微球通过激活内源性再生促进大鼠心肌梗死模型中的心脏修复。

Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.

机构信息

Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain.

Hematology, Cardiology and Cell Therapy, Clínica Universidad de Navarra, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.

出版信息

J Control Release. 2014 Jan 10;173:132-9. doi: 10.1016/j.jconrel.2013.10.034. Epub 2013 Nov 5.

Abstract

Acidic fibroblast growth factor (FGF1) and neuregulin-1 (NRG1) are growth factors involved in cardiac development and regeneration. Microparticles (MPs) mediate cytokine sustained release, and can be utilized to overcome issues related to the limited therapeutic protein stability during systemic administration. We sought to examine whether the administration of microparticles (MPs) containing FGF1 and NRG1 could promote cardiac regeneration in a myocardial infarction (MI) rat model. We investigated the possible underlying mechanisms contributing to the beneficial effects of this therapy, especially those linked to endogenous regeneration. FGF1- and NRG1-loaded MPs were prepared using a multiple emulsion solvent evaporation technique. Seventy-three female Sprague-Dawley rats underwent permanent left anterior descending coronary artery occlusion, and MPs were intramyocardially injected in the peri-infarcted zone four days later. Cardiac function, heart tissue remodeling, revascularization, apoptosis, cardiomyocyte proliferation, and stem cell homing were evaluated one week and three months after treatment. MPs were shown to efficiently encapsulate FGF1 and NRG1, releasing the bioactive proteins in a sustained manner. Three months after treatment, a statistically significant improvement in cardiac function was detected in rats treated with growth factor-loaded MPs (FGF1, NRG1, or FGF1/NRG1). The therapy led to inhibition of cardiac remodeling with smaller infarct size, a lower fibrosis degree and induction of tissue revascularization. Cardiomyocyte proliferation and progenitor cell recruitment were detected. Our data support the therapeutic benefit of NRG1 and FGF1 when combined with protein delivery systems for cardiac regeneration. This approach could be scaled up for use in pre-clinical and clinical studies.

摘要

酸性成纤维细胞生长因子(FGF1)和神经调节蛋白 1(NRG1)是参与心脏发育和再生的生长因子。微粒(MPs)介导细胞因子的持续释放,可用于克服系统给药时治疗性蛋白稳定性有限的相关问题。我们试图研究含有 FGF1 和 NRG1 的微粒(MPs)给药是否可以促进心肌梗死(MI)大鼠模型中的心脏再生。我们研究了这种治疗可能发挥有益作用的潜在机制,特别是与内源性再生相关的机制。使用多乳液溶剂蒸发技术制备 FGF1 和 NRG1 负载的 MPs。73 只雌性 Sprague-Dawley 大鼠进行永久性左前降支冠状动脉结扎,四天后在梗死周边区心肌内注射 MPs。治疗后一周和三个月评估心脏功能、心脏组织重构、再血管化、细胞凋亡、心肌细胞增殖和干细胞归巢。结果表明 MPs 能够有效地包封 FGF1 和 NRG1,并以持续的方式释放生物活性蛋白。治疗三个月后,用载有生长因子的 MPs(FGF1、NRG1 或 FGF1/NRG1)治疗的大鼠心脏功能有明显改善。该治疗方法抑制了心脏重构,减小了梗死面积,降低了纤维化程度,并诱导了组织再血管化。检测到心肌细胞增殖和祖细胞募集。我们的数据支持 NRG1 和 FGF1 与蛋白质递送系统联合用于心脏再生的治疗益处。这种方法可以扩大用于临床前和临床研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验